Related Experiment Videos

Inactivation of the p15INK4B and p16INK4 genes in hematologic malignancies

M Heyman1, S Einhorn

  • 1Radiumhemmet, Karolinska Hospital, Stockholm, Sweden.

Leukemia & Lymphoma
|October 1, 1996
PubMed

Insights

The p15INK4B and p16INK4 genes regulate cell cycles and are crucial in tumorigenesis. Their inactivation is common in cancers, making them significant prognostic markers for hematologic malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p15INK4B and p16INK4 genes encode cell cycle regulatory proteins and are located on chromosome 9p21, a region frequently deleted in malignant diseases.
  • The p16INK4 gene is a tumor suppressor gene, frequently inactivated in various cancers, and is the second most mutated gene after p53 in human malignancies.
  • The role of p15INK4B and p16INK4 in hematologic malignancies is under intense investigation.

Purpose of the Study:

  • To review the function and role in tumorigenesis of the p15INK4B and p16INK4 genes.
  • To discuss the significance of these genes as prognostic markers in hematologic malignancies.

Main Methods:

  • Literature review of studies investigating p15INK4B and p16INK4 genes.
  • Analysis of gene function, mutation status, and clinical significance in hematologic malignancies.

Main Results:

  • p15INK4B and p16INK4 genes are frequently altered in malignant diseases.
  • Inactivation of p16INK4 is a common event in cancer, highlighting its tumor suppressor role.
  • These genes show potential as prognostic markers in hematologic malignancies.

Conclusions:

  • The p15INK4B and p16INK4 genes play a significant role in cell cycle regulation and tumorigenesis.
  • Their inactivation is a hallmark of many cancers, particularly hematologic malignancies.
  • Further research into these genes can lead to improved prognostic tools for cancer patients.

Related Concept Videos